Support Access To A New Therapy


Following marketing approval, your group may continue to play a role in ensuring the new therapy is accessible and available to your disease community. Enabling broad access to a newly approved therapy often requires working with public and private insurance providers about these new changes in patient care to inform appropriate decisions on coverage. 

Currently there is a lot of debate concerning the cost of accessing cutting edge therapies, but no clear solutions. Thus, there are limited resources providing tips or strategies available on this topic. As patient groups and other key stakeholders work together to find ways to ensure accessibility, more information and relevant resources will be added to this section. 

You are encouraged to share any helpful resources, tips, or strategies that your group used to successfully address access barriers to a new therapy in your disease community for possible addition to NCATS Toolkit through the Contact Page . You may also wish to share current challenges and even strategies that have not been successful.